A TRANSCRIPTION FACTOR

Abstract: A transcription factor regulating alpha -amylase promoter initiated expression in filamentous fungi, especially in Aspergillii, DNA sequences coding for said factor, its transformation into and expression in fungal host organisms, and the use of said factorin such hosts for increasing the expression of a polypeptide of interest being produced by said host.

Description: Title: A Transcription Factor FIELD OF THE INVENTION The present invention relates to a transcription factor found in filamentous fungi, especially in Aspergillii , DNA sequences coding for said factor, its transformation into and expression in fungal host organisms, and the use of said factor in such hosts for increasing the expression of a polypeptide of interest being produced by said host. BACKGROUND OF THE INVENTION Transcription factors are well known proteins involved in the initiation of transcription. They have been studied intensively in many different organisms and have also been described in fungi. Dhawale and Lane (NA (1993) 21 5537-5546) have recently compiled the transcription factors from fungi, including the filamentous fungi. Many of the transcription factors are regulatory proteins; they bind to the promoter DNA and either activate or repress transcription as a response to stimuli to the cell . The expression of the α-amylase gene in A . oryzae is regulated in response to the available carbon source. The gene is expressed at its maximum when the organism is grown on starch or maltose (Lachmund et al . (1993) Current Microbiology 26 47-51; Tada et al . (1991) Mol . Gen . Genet . 229 301-306). The expression of α-amylase is regulated at the transcriptional level as shown by Lachmund et al . { supra) , which strongly suggests that transcription factors are involved in the regulation, but so far no gene for such a factor has been identified. The promoter of the α-amylase gene has been studied by deletion analysis (Tada et al . (1991) Agric . Biol . Chem. 55 1939-1941; Tsuchiya et al . (1992) Biosci . Biotech . Bioche . 56 1849-1853; Nagata et al . (1993) Mol . Gen . Genet . 237 251-260). The authors of these papers propose that a specific sequence of the promoter is responsible for the maltose induction. Nagata et al . ( supra) used this sequence as a probe in a gel shift experiment to see whether any proteins from A . nidulans nuclear extracts were able to bind to the promoter sequence. Three such proteins were found, but no involvement of these proteins in expression was shown. None of the proteins have been purified or identified by other means. Their genes likewise remain unknown. SUMMARY OF THE INVENTION The present invention relates to a transcription factor regulat- ing the expression of the α-amylase promoter in filamentous fungi . Accordingly, in a first aspect the invention relates to a DNA construct comprising a DNA sequence encoding a transcription factor of the invention, which DNA sequence comprises a) the transcription factor encoding part of the DNA sequence cloned into plasmid pToC320 present in E. coli ToC1058, DSM 10666, or b) an analogue of the DNA sequence defined in a) , which i) is at least 60% homologous with the DNA sequence defined in a) , or ii) hybridizes with the same nucleotide probe as the DNA sequence defined in a) , or iii) encodes a transcription factor which is at least 50% homologous with the transcription factor encoded by a DNA sequence comprising the DNA sequence defined in a) , or iv) encodes a transcription factor which is immunologically reactive with an antibody raised against the purified transcription factor encoded by the DNA sequence defined in a) , or v) complements the mutation in ToC879, i.e. enables ToC879 to grow on cyclodextrin and produce lipase when transformed with said DNA sequence . The full length genomic DNA sequence encoding a transcription factor has been derived from a strain of the filamentous fungus Aspergillus oryzae and has been cloned into plasmid pToC320 present in E. coli ToC1058, DSM 10666. Said transcription factor encoding DNA sequence harboured in pToC320, DSM 10666, is believed to have the same sequence as that presented in SEQ ID NO: 1 and SEQ ID NO: 2. Accordingly, whenever reference is made to the transcription factor encoding part of the DNA sequence cloned into plasmid pToC320 present in DSM 10666 such reference is also intended to include the transcription factor encoding part of the DNA sequence presented in SEQ ID NO: 1 and SEQ ID NO : 2. Accordingly, the terms "the transcription factor encoding part of the DNA sequence cloned into plasmid pToC320 present in DSM 10666" and "the transcription factor encoding part of the DNA sequence presented in SEQ ID NO: 1 and SEQ ID NO: 2" may be used interchangeably. In further aspects the invention provides an expression vector harbouring the DNA construct of the invention, a cell comprising said DNA construct or said expression vector and a method of producing a peptide exhibiting transcription factor activity, which method comprises culturing said cell under conditions permitting the production of the transcription factor. Such a transcription factor of the invention will typically originate from a filamentous fungus. The term "filamentous fungus" is intended to include the groups Phycomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and fungi imperfecti, including Hyphomycetes such as the genera Aspergillus, Peni cillium, Trichoderma, Fusarium and Humicola . The invention also relates to a method of producing a filamentous fungal host cell comprising the introduction of a DNA fragment coding for any such factor into a filamentous fungus wherein an α-amylase promoter or a co-regulated promoter regulates the expression of a polypeptide of interest in a manner whereby said factor will be expressed in said fungus. In a further aspect the invention relates to a method of producing a polypeptide of interest, the expression of which is regulated by an α-amylase promoter or a co-regulated promoter, comprising growing a filamentous fungal host cell as described above under conditions conducive to the production of said factor and said polypeptide of interest, and recovering said polypeptide of interest. Finally the invention relates to the use of said factor for regulating the expression of a polypeptide of interest in a filamentous fungus. In this context, regulation means to change the conditions under which the factor of the invention is active. This could mean different pH, substrate, etc. regimes, whereby the resulting effect is an improved regulation of the expression of the protein of interest . Furthermore, regulation also comprises events occurring in the growth phase of the fungus during which the transcription factor is active. Depending on the circumstances, both advancing and/or postponing the phase wherein the factor is active may enhance the expression and thus the yield. In addition, using standard procedures known in the art, the specific DNA sequences involved in the binding of a transcription factor may be identified, thereby making it possible to insert such sequences into other promoters not normally regulated by the factor and enabling those promoters to be under the regulation of said factor. BRIEF DESCRIPTION OF THE TABLES AND DRAWING In the figures Fig. 1 shows the structure of the plasmid pMT1657, the construction of which is described in Example 1; Fig. 2 shows the structure of the plasmid pToC316, the construction of which is described in Example 1; Fig. 3 shows the structure of the plasmid pToC320, the construction of which is described in Example 1; Fig. 4 shows the structure of the plasmids pToC342 and pToC359, the construction of which are described in Example 3; Fig. 5 shows the structure of the plasmid pToC298, the construction of which is described in Example 4; Fig. 6 shows the results of lipase production by a p960 transformant of A . oryzae IF04177 cultured in YP media containing 2% glucose (—■—) or 10% glucose (—♦—) , in comparison to ToC1075 cultured in YP media containing 2% glucose (—D—) or 10% glucose (—0—) and described in Example 4 ; Fig. 7 shows the results of lipase production by ToC1139 cultured in YP media containing 2% glucose (—■—) or 10% glucose (—♦—) , in comparison to ToC1075 cultured in YP media containing 2% glucose (—D—) or 10% glucose (—0—) and described in Example 4 ; and Fig. 8 shows the autoradiograph results of A . niger DNA digested with the following restriction enzymes: lane 2, Xbal; lane 3, Xmal; lane 4, Sail; lane 5, Hindlll; lane 6, EcoRI; lane 7, Bglll; lane 8, BamHI; lanes 1 and 9 contain 32 P-labelled 1 DNA digested with BstEII. The experiment is described in Example 5. DETAILED DESCRIPTION OF THE INVENTION In a first aspect the invention relates to a DNA construct comprising a DNA sequence encoding a transcription factor regulating an α-amylase promoter, which DNA sequence comprises a) the transcription factor encoding part of the DNA sequence cloned into plasmid pToC320 present in E. coli ToC1058, DSM 10666, or b) an analogue of the DNA sequence defined m a) , which l) is at least 60% homologous with the DNA sequence defined m a) , or li ) hybridizes with the same nucleotide probe as the DNA sequence defined m a) , or in) encodes a transcription factor which is at least 50% homologous with the transcription factor encoded by a DNA sequence comprising the DNA sequence defined in a) , or IV) encodes a transcription factor which is immunologically reactive with an antibody raised against the purified transcription factor encoded by the DNA sequence defined m a), or v) complements the mutation in ToC879, i . e . enables ToC879 to grow on cyclodextrin and produce lipase when transformed with said DNA sequence. As defined herein, a DNA sequence analogous to the transcription factor encoding part of the DNA sequence cloned into plasmid pToC320 present in E. coli ToC1058, DSM 10666, is intended to indicate any DNA sequence encoding a transcription factor regulating an α-amylase promoter, which transcription factor has one or more of the properties cited under (I) - (v) above. The analogous DNA sequence may be isolated from a strain of the filamentous fungus A . oryzae producing the transcription factor, or another or related organism and thus, e.g. be an allelic or species variant of the transcription factor encoding part of the DNA sequence cloned into plasmid pToC320 present in DSM 10666. Alternatively, the analogous sequence may be constructed on the basis of the DNA sequence presented as the transcription factor encoding part of SEQ ID NO: 1 and SEQ ID NO: 2, e . g. be a sub- sequence thereof, and/or by introduction of nucleotide substitutions which do not give rise to another amino acid sequence of the transcription factor encoded by the DNA sequence, but which corresponds to the codon usage of the host organism intended for production of the transcription factor, or by introduction of nucleotide substitutions which may give rise to a different amino acid sequence. When carrying out nucleotide substitutions, amino acid residue changes are preferably of a minor nature, that is conservative amino acid residue substitutions that do not significantly affect the folding or activity of the protein, small deletions, typically of one to about 30 amino acid residues; small amino- or carboxyl-terminal extensions. Examples of conservative substitutions are within the group of basic amino acids (such as arginine, lysine, histidine) , acidic amino acids (such as glutamic acid and aspartic acid) , polar amino acids (such as glutamine and asparagine) , hydrophobic amino acids (such as leucine, isoleucine, valine) , aromatic amino acids (such as phenylalanine, tryptophan, tyrosine) and small amino acids (such as glycine, alanine, serine, threonine, methionine) . For a general description of nucleotide substitution, see e . g. Ford, et al . , (1991), Protein Expression and Purification 2, 95-107. It will be apparent to persons skilled in the art that such substitutions can be made outside the regions critical to the function of the molecule and still result in an active transcription factor. Amino acid residues essential to the activity of the transcription factor encoded by a DNA construct of the invention, and therefore preferably not subject to substitution, may be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (cf. e . g. Cunningham and Wells, (1989), Science 244 1081-1085) . In the latter technique mutations are introduced at every residue in the molecule, and the resultant mutant molecules are tested for biological activity (i.e. transcription factor regulating an α-amylase promoter) to identify amino acid residues that are critical to the activity of the molecule. The homology referred to in (i) above is determined as the degree of identity between the two sequences indicating a derivation of the one sequence from the other. The homology may suitably be determined by means of computer programs known in the art such as GAP provided in the GCG program package (Needleman, S.B. and Wunsch, CD., (1970), Journal of Molecular Biology 48 443-453) . Using GAP with the following settings for DNA sequence comparison: GAP creation penalty of 5.0 and GAP extension penalty of 0.3, the coding region of the DNA sequence exhibits a degree of identity preferably of at least 60%, more preferably at least 70%, more preferably at least 80%, more preferably at least 90%, more preferably at least 95% with the transcription factor encoding part of the DNA sequence shown in SEQ ID NO: 1 and SEQ ID NO: 2. The hybridization referred to in (ii) above is intended to indicate that the analogous DNA sequence hybridizes to the same probe as the DNA sequence encoding the transcription factor under certain specified conditions, which are described in detail in the Materials and Methods section hereinafter. The oligonucleotide probe to be used is the DNA sequence corresponding to the transcription factor encoding part of the DNA sequence shown in SEQ ID NO: 1 or SEQ ID NO: 2 or a fragment thereof . The homology referred to in (iii) above is determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second. The homology may suitably be determined by means of computer programs known in the art such as GAP provided in the GCG program package (Needleman, S.B. and Wunsch, CD., supra) . Using GAP with the following settings for transcription factor sequence comparison: GAP creation penalty of 3.0 and GAP extension penalty of 0.1, the transcription factor encoded by an analogous DNA sequence exhibits a degree of identity preferably of at least 50%, more 5 preferably at least 60%, more preferably at least 70%, even more preferably at least 80%, especially at least 90% with the transcription factor encoded by a DNA construct comprising the transcription factor encoding part of the DNA sequence shown in SEQ ID NO: 2, e.g. with the amino acid sequence SEQ ID NO: 3. 10 In connection with property (iv) the immunological reactivity may be determined by the method described in the Materials and Methods section hereinafter. 15 In relation to the property (v) the complementation method is described in Example 1 herein. The DNA sequence encoding a transcription factor of the invention can be isolated from the strain Aspergillus oryzae IFO 20 4177 using standard methods e. g. as described by Sambrook, et al . , (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Lab.; Cold Spring Harbor, NY. General RNA and DNA isolation methods are also disclosed in WO 25 93/11249 and WO 94/14953, the contents of which are hereby incorporated by reference. A more detailed description of the complementation method is given in Example 1 herein. Alternatively, the DNA encoding a transcription factor of the 30 invention may, in accordance with well-known procedures, be conveniently isolated from a suitable source, such as any of the below mentioned organisms, by use of synthetic oligonucleotide probes prepared on the basis of a DNA sequence disclosed herein. For instance, a suitable oligonucleotide probe may be prepared 35 on the basis of the transcription factor encoding part of the nucleotide sequences presented as SEQ ID NO: 1 or any suitable subsequence thereof, or on the basis of the amino acid sequence SEQ ID NO : 3. The invention relates specifically to a transcription factor regulating the expression of the α-amylase promoter in a filamentous fungus, which factor as indicated in Example 2 may even regulate the expression of other genes. In this context the expression "filamentous fungus" is intended to include the groups Phycomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and fungi imperfecti, including Hyphomycetes such as the genera Aspergillus, Penicillium, Trichoderma, Fusarium and Humicola . In this context the expression "α-amylase promoter" means a sequence of bases immediately upstream from an α-amylase gene which RNA polymerase recognises and binds to promoting transcription of the gene coding for the α-amylase. As indicated, transcription factors are known from many organisms and it is therefore expected that similar or cor- responding factors may be found originating from other fungi of the genera Aspergillus, Trichoderma, Penicillium, Fusarium, Humicola, etc., having an enhancing effect on the expression of a polypeptide being under the regulation of amylase promoters in any fungus belonging to any of these genera . A comparison of the DNA sequence coding for the transcription factor regulating the α-amylase promoter has shown some degree of homology to a transcription factor (CASUCI) regulating the expression of glucosidase in Candida and to MAL63 of Saccharomyces cerevisiae as disclosed in Kelly and Kwon-Chung, (1992) J. Bacteriol . 174 222-232. It is at present contemplated that a DNA sequence encoding a transcription factor homologous to the transcription factor of the invention, i.e. an analogous DNA sequence, may be obtained from other microorganisms. For instance, the DNA sequence may be derived by a similar screening of a cDNA library of another microorganism, such as a strain of Aspergillus, Saccharomyces , Erwinia , Fusarium or Trichoderma . An isolate of a strain of A . oryzae from which the gene coding for a transcription factor of the invention has been inactivated has been deposited by the inventors according to the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure at the DSM, Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Mascheroder Weg lb, D-38124 Braunschweig, DEUTSCHLAND. Deposit date : 6 MAY 1996 (06.05.96) Depositor's ref . : ToC879 = NN049238 DSM designation: Aspergillus oryzae DSM No.10671 The deposited strain Aspergillus oryzae DSM No.10671 can be used to isolate a transcription factor according to the invention from any strain of Aspergillus oryzae and any other fungal strain having such a gene by complementation as described hereinafter. The expression plasmid pToC320 comprising the full length genomic DNA sequence encoding the transcription factor of the invention has been transformed into a strain of E. coli resulting in the strain ToC1058, which has been deposited by the inventors according to the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure at the DSMZ, Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH. , Mascheroder Weg lb, D- 38124 Braunschweig, DEUTSCHLAND. Deposit date : 6 MAY 1996 (06.05.96) Depositor's ref. : ToC1058 = NN049237 DSM designation: E. coli DSM No.10666 According to the invention, factors of this type originating from the species A . oryzae, A . niger, A . awamori , etc., especially A . oryzae IF04177 are preferred. The transcription factor of the invention has been found not only to be involved in the regulation of the α-amylase promoter, but also in the regulation of the glucoamylase promoter from A . oryzae. Especially, the invention comprises any factor having an amino acid sequence comprising one or more fragments or combinations of fragments of the amino acid sequence depicted as SEQ ID NO: 3. Truncated forms of the transcription factor may also be active. By truncated forms are meant modifications of the transcription factor wherein N-terminal, C-terminal or one or more internal fragments have been deleted. A further aspect of the invention relates to a DNA sequence coding for any of these factors. In this aspect the invention especially comprises any DNA sequence coding for one or more fragments of the amino acid sequence depicted as SEQ ID NO: 3. More specifically the invention relates to a DNA sequence comprising one or more fragments or a combination of fragments of the DNA sequence depicted as SEQ ID NO: 1 and SEQ ID NO: 2. According to a further aspect the invention relates to a method of producing a filamentous fungal host cell comprising the introduction of any of the above mentioned DNA fragments into a filamentous fungus wherein the α-amylase promoter or another co- regulated promoter regulates the expression of a polypeptide of interest in a manner whereby said factor will be expressed in said fungus. The introduction of said DNA fragment may be performed by means of any well known standard method for the introduction of DNA into a filamentous fungus, such as by use of an expression vector and host cells as described below. Therefore, the invention also provides a recombinant expression vector comprising the DNA construct of the invention. The expression vector of the invention may be any expression vector that is conveniently subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid. Alternatively, the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome (s) into which it has been integrated. In the expression vector, the DNA sequence encoding the transcription factor should either also contain the expression signal normally associated with the transcription factor or should be operably connected to a suitable promoter and terminator sequence . The promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes that are either homologous or heterologous to the host cell. The procedures used to ligate the DNA sequences coding for the transcription factor, the promoter and the terminator, respectively, and to insert them into suitable vectors are well known to persons skilled in the art (cf., Sambrook, et al . , supra) . Examples of suitable promoters for use in filamentous fungal host cells are, for instance, the A . nidulans ADH3 promoter (McKnight, et al . (1985) The EMBO J. 4 2093-2099) or the tpiA promoter. Examples of other useful promoters are those derived from the gene encoding Aspergillus oryzae α-amylase, Aspergillus niger neutral a-amylase, Aspergillus niger acid stable a- amylase, Aspergillus niger, Aspergillus awa ori , or Aspergillus . oryzae glucoamylase (gluA) , A . oryzae alkaline protease (alp) , A . oryzae nitrate reductase (niaD) , Aspergillus oryzae triose phosphate isomerase (tpi), Aspergillus nidulans acetamidase, or an Aspergillus promoter coding for an amino acid biosynthetic gene such as argB. In yet another aspect the invention provides a host cell comprising the DNA construct of the invention and/or the recombinant expression vector of the invention. Preferably, the host cell of the invention is a eukaryotic cell, in particular a fungal cell such as a yeast or filamentous fungal cell. In particular, the cell may belong to a species of Trichoderma, preferably Trichoderma harzianum or Trichoderma reesei , or a species of Aspergillus, most preferably Aspergillus oryzae or Aspergillus niger. Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall in a manner known per se . The use of Aspergillus as a host microorganism is described in EP 238 023 (Novo Nordisk A/S) , the contents of which are hereby incorporated by reference. The host cell may also be a yeast cell, e. g. a strain of Saccharo yces , in particular Saccharomyces cerevisiae, Saccharomyces kluyveri or Saccharomyces uvarum, a strain of Schizosaccharomyces sp., such as Schizosaccharomyces pombe, a strain of Hansenula sp., Pichia sp. , Yarrowia sp., such as Yarrowia lipolytica, or Kluyveromyces sp., such as Kluyveromyces lactis . The endogenous amyR gene of the host cell may be deleted or inactivated by other means. The introduction of amyR control by a heterologous promoter will then lead to a completely new scheme of regulation of the a-amylase promoter. If, for example, amyR is fused to the A . oryzae niaD promoter, the a- amylase promoter will become inducible by nitrate. If, instead of the niaD promoter, a palC-regulated promoter is used, the activity of the a-amylase promoter will be regulated by pH . The invention also comprises a method of producing a polypeptide of interest, whereby a host cell as described above is grown under conditions conducive to the production of said factor and said polypeptide of interest, and said polypeptide of interest is recovered. The medium used to culture the transformed host cells may be any conventional medium suitable for growing the host cells in question. The expressed polypeptide of interest may conveniently be secreted into the culture medium and may be recovered therefrom by well-known procedures including separating the cells from the medium by centrifugation or filtration, precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like. According to the invention the method may be used to produce a polypeptide of interest that is a medicinal polypeptide, especially such medicinal polypeptides as growth hormone, insulin, blood clotting factor, and the like. The method of the invention may also be used for the production of industrial enzymes, such as proteases, lipases, amylases, glucoa ylases, oxido reductases, carbohydrases, carbonyl hydrolases, cellulases, esterases, etc. According to a further aspect of the invention said transcrip- tion factor may be used for enhancing the expression of a polypeptide of interest in a filamentous fungus, such as a fungus of the genus Aspergillus, Trichoderma, Penicillium, Fusarium, Humicola, etc., especially of the species A . oryzae, A . niger, A . awamori , etc., and specifically A . oryzae. The transcription factor of the invention may thus be used to enhance the expression of a medicinal polypeptide, such as growth hormone, insulin, blood clotting factor, etc. Also, the expression of industrial enzymes, such as proteases, upases, amylases, glucoamylases, oxido reductases, carbohydrases, carbonyl hydrolases, cellulases, esterases, etc., may be enhanced by the use of the transcription factor of the invention. The transcription factor may also be used to identify the sequences in the a-amylase promoter to which it binds. For example, this could be done by making a GST-fusion protein with the DNA binding domain of AmyR, such as the zinc finger, for production in E. coli . Such fusion proteins may be conveniently made using commercially available kits, for example, "The GST Gene Fusion Kit" from Pharmacia. The purified GST-fusion protein can then be used in conventional in vi tro techniques such as gel shift assays or DNA footprint analyses (Kulmburg, P., et al . (1992) Molecular and Cellular Biology 12 1932-1939; Lutfiyya, L.L., and Johnston, M. (1996) Molecular and Cellular Biology 16 4790-4797) . The identification of the AmyR binding site will make it possible to insert these sequences in other promoters not normally regulated by AmyR. MATERIALS AND METHODS Hybridization: Suitable hybridization conditions for determining hybridization between a nucleotide probe and an "analogous" DNA sequence of the invention may be defined as described below. The oligonucleotide probe to be used is the DNA sequence corresponding to the transcription factor encoding part of the DNA sequence shown in SEQ ID NO: 1, i.e. nucleotides 1691..2676 + 2743..3193 + 3278..3653 in SEQ ID NO: 1, or a fragment thereof, e.g. nucleotides 1770-1800 in SEQ ID NO: 1. Hybridization conditions Suitable conditions for determining hybridization between a nucleotide probe and a homologous DNA or RNA sequence involves pre-soaking of the filter containing the DNA fragments or RNA to hybridize in 5x SSC (standard saline citrate buffer) for 10 min, and prehybridization of the filter in a solution of 5x SSC (Sambrook, et al . , supra) , 5x Denhardt ' s solution (Sambrook, et 5 al . , supra) , 0.5 % SDS and 100 μg/ml of denatured sonicated salmon sperm DNA (Sambrook, et al . , supra) , followed by hybridization in the same solution containing a random-primed (Fein- berg, A. P. and Vogelstein, B. (1983) Anal . Biochem. 132 6-13), 32 P-dATP- labeled (specific activity > 1 x 10 9 cpm/μg) probe for 10 12 hours at ca . 65°C The filter is then washed two times for 30 minutes in 2x SSC, 0.5 % SDS at preferably not higher than 50°C, more preferably not higher than 55°C, more preferably not higher than 60°C, more preferably not higher than 65°C, even more preferably not higher than 70°C, especially not higher than 15 75°C Molecules to which the nucleotide probe hybridizes under these conditions are detected using a Phospho Image detector. 20 Im unological cross-reactivity: Antibodies to be used in determining immunological cross- reactivity may be prepared by use of a purified transcription factor. More specifically, antiseru against the transcription factor of the invention may be raised by immunizing rabbits (or 25 rodents) according to the procedure described by N. Axelsen et al . in: A Manual of Quantitative Immunoelectrophoresis, Blackwell Scientific Publications, 1973, Chapter 23, or A. Johnstone and R. Thorpe, Immunochemistry in Practice, Blackwell Scientific Publications, 1982 (more specifically pp. 27-31) . 30 Purified immunoglobulins may be obtained from the antisera, for example by salt precipitation ((NH 4 ) 2 S0 4 ) , followed by dialysis and ion exchange chromatography, e.g. on DEAE-Sephadex. Im- munochemical characterization of proteins may be done either by Outcherlony double-diffusion analysis (0. Ouchterlony in: 35 Handbook of Experimental Immunology (D.M. Weir, ed.), Blackwell Scientific Publications, 1967, pp. 655-706) , by crossed immunoelectrophoresis (N. Axelsen et al . , supra, Chapters 3 and 4), or by rocket immunoelectrophoresis (N. Axelsen et al . , op ci t . , Chapter 2) . EXAMPLES EXAMPLE 1 Cloning of the amyR transcription factor from A. oryzae amyR was cloned by complementation of an A. oryzae mutant strain unable to express two different proteins both under control of the TAKA-amylase promoter. The mutant A . oryzae strain ToC879 was made by mutagenesis of a strain, SRe440, containing a lipase (HLL) encoding cDNA under control of the TAKA promoter and one copy of the TAKA-a ylase gene transcribed from its own promoter. The mutant was identified and isolated by its amylase negative (amylase " ) phenotype and subsequently shown to be lipase negative (lipase) as well. The strain ToC879 contains intact copies of both expression cassettes. The amylase " phenotype makes ToC879 unable to grow on plates containing 1% cyclodextrin as the sole carbon source, while the parent strain SRe440 will grow on such plates. ToC879 has been deposited at DSM under the name DSM No.10671. amyR was isolated by co-transforming ToC879 with an A . oryzae cosmid library and an autonomously replicating pHelpl based plasmid (D. Gems, I. L. Johnstone, and A. J. Clutterbuck (1991) Gene 98 61-67) carrying the bar gene from Strepto/nyces hygroscopicus which confers resistance to glufosinate. The transformants were subjected to selection on plates containing cyclodextrin as the sole carbon source and screened for a concurrent reversion to the lipase * phenotype. The transforming DNA was rescued from colonies able to grow on cyclodextrin. Subcloning resulted in the isolation of a 4.3 kb DNA fragment able to complement both phenotypes of ToC879. The gene harboured on this fragment was named amyR . Construction of the pHelpl derivative pMT1657 A plasmid, pMT1612, was made by ligation (and subsequent transformation into E. coli DH5a) of the following four fragments: i) the E. coli vector pToC65 (described in EP 531 372) cut with Sphl/Xbal, ii) a PCR fragment (containing the A . nidulans amdS promoter) cut with SphI /BamHI, iii) a 0.5 kb BamHl/XhoI fragment from pBPIT (B. Staubinger et al . , (1992) Fungal Genetics Newsletter 39 82-83) containing the ar gene, and iv) a 0.7 kb Xhol/Xbal fragment from pIC AMG/Term (EP Application No. 87103806.3) containing the A . niger glucoamylase transcription terminator. The PCR fragment containing the amdS promoter was made using the plasmid pMSX-6Bl (M. E. Katz et al . , (1990) Mol . Gen . Genet . 220 373-376) as substrate DNA and the two oligonucleotides 4650 (SEQ ID NO: 4) and 4561 (SEQ ID NO: 5) as primers. 4650: CTTGCATGCCGCCAGGACCGAGCAAG, SEQ ID NO: 4 4651: CTTGGATCCTCTGTGTTAGCTTATAG . SEQ ID NO: 5 pMSX-6Bl contains an amdS promoter up mutation called 1666. pMT1612 was cut with Hindlll, dephosphorylated and ligated to a 5.5 kb Hindi 11 fragment from pHelpl containing the AMA1 sequence. The resulting plasmid, pMT1657 is self-replicating in Aspergilli and can be selected for by increased resistance to glufosinate. pMT1657 is depicted in Fig. 1, wherein PamdS represents the amdS promoter of fragment ii) above, bar represents fragment iii) above, and Tamg represents fragment iv) above . Construction of the cosmid library A cosmid library of Aspergillus oryzae was constructed essentially according to the instructions from the supplier of the "SuperCosl cosmid vector kit" (Stratagene Cloning Systems, La Jolla CA, USA) . Genomic DNA of A . oryzae IF04177 was prepared from protoplasts made by standard procedures (Christensen, T. , et. al . (1988) Biotechnology 6 1419-1422) . After isolation the protoplasts were pelleted by centrifugation at 2500 rpm for 5 minutes in a Labofuge T (Heto) ; the pellet was then suspended in 10 mM NaCl, 20 mM Tris-HCl (pH 8.0), 1 mM EDTA, 100 μg/ml proteinase K and 0.5% SDS as stated in the manual from the Supercos 1 cosmid vector kit; the rest of the DNA preparation was done according to the instructions of the kit. The size of the genomic DNA was analysed by electrophoresis using the CHEF-gel apparatus (Bio-Rad Laboratories, Hercules CA, USA) . A 1% agarose gel was run for 20 hours at 200 volts with a 10-50 second pulse. The gel was stained with ethidium bromide and photographed. The DNA was 50->100 kb in size. The DNA was partially digested using Sau3A. The size of the digested DNA was 20-50 kb determined by the same type of CHEF-gel analysis as above. The CsCl gradient banded SuperCosl vector was prepared according to the manual. Ligation and packaging were likewise performed as described in the manual. After titration of the library, all of the packaging mix from one ligation and packaging was transfected into the host cells, XLl-Blue MR, and plated on 50 μg/ml ampicillin LB plates. Approximately 3800 colonies were obtained. Cosmid preparations from 10 colonies showed that they all had inserts of the expected size. The colonies were picked individually and inoculated in microtiter plate wells with 100 μl LB (100 μg/ml ampicillin) and incubated at 37°C overnight. 100 μl of 50% glycerol was added to each well, and the entire library was frozen at -80°C A total of 3822 colonies were stored. This represents the A . oryzae genome approximately 4.4 times. After picking the colonies the plates were scraped off, the scrape-off pooled and the total library was also stored in four pools as frozen glycerol stock. The four pools were named ToC901-ToC904. The individually frozen colonies in the library were inoculated onto LB-plates (100 μg/ml ampicillin) by using a multipin device of 6 rows of 8 pins fitting into half a microtiter dish. Plates were made containing colonies from all clones in the library. The plates were incubated at 37°C overnight. Sterilized Whatman 540 filters cut to the size of a petri dish were placed upon the colonies which were incubated for two more hours at 37°C. The filters were transferred to LB plates containing 200 μg/ml of chloramphenicol and the plates were incubated overnight at 37 °C. The next day the filters were washed twice in 0.5 M NaOH for 5 minutes, then twice in 0.5 M Tris-HCl (pH7.4) for 5 minutes and then twice in 2x SSC for 5 minutes. The filters were wetted with ethanol and air dried. Selection of amyR clones Cosmid DNA was prepared from ToC901-904 and introduced into ToC879 by co-transformation with pMT1657. The transformation procedure is described in EP Application No. 87103806.3. Approximately 8700 transformants were selected by resistance to 1 mg/ml glufosinate in minimal plates (Cove D.J. (1966) BBA 113 51-56) containing 1 M sucrose for osmotic stabilization and 10 mM (NH 4 ) 2 S0 4 . Ten randomly chosen transformants were reisolated once on the same type of plates. Conidiospores from these 10 transformants were inoculated in minimal medium containing 1 mg/ml glufosinate and grown at 30°C until enough mycelium for DNA preparation could be harvested. DNA was prepared as described in T. Chris- tensen et al . { supra) . The uncut DNA was applied to a 0.7% agarose gel, and electropho- resis was performed, followed by Southern blotting. The blot was hybridized with a 32 P-labelled SuperCosl specific DNA fragment. Each of the ten transformants showed a band with a higher mobility than the linear chromosomal DNA. Each of the bands also hybridized to a pHelpl specific probe, indicating that the co-transformation frequency of the cosmid library was close to 100% and that the cosmids had integrated into the autonomously replication vector pHelpl. The transformants were unstable as expected for pHelpl transformants. Less than 10% of the conidiospores from a glufosinate resistant colony gave rise to glufosinate-resistant progeny. Conidiospores from all the transformants were collected in 8 pools and plated on minimal plates (Cove D. J. , supra) containing 1 mg/ml glufosinate, 10 mM (NH 4 ) 2 S0 4 and 1% b-cyclodextrin (Kleptose from Roquette Freres', 62136 Lestem, France) Four colonies were obtained from one of the pools and one from one of the other pools. Two of the colonies from the first pool were reisolated once on the same kind of plates. Conidiospores from the reisolated colonies were plated on minimal plates with either glucose or cyclodextrin as a carbon source and on glufosinate-containing plates. The glufosinate resistance and the ability to grow on cyclodextrin were both unstable phenotypes with the same degree of instability. This indicated that the gene conferring the ability to grow on cyclodextrin was physically linked to pMT1657 in the transfor- mants . Colonies from the reisolation plates were cut out and were analysed by rocket immune electrophoresis (RIE) using an antibody raised against the HLL lipase. The transformants gave a clear reaction with the antibody, while ToC879 colonies grown on maltose gave no reaction. This led to the conclusion that both the expression of amylase (i.e., growth on cyclodextrin) and lipase (i.e. antibody binding) had been restored in these transformants. The gene responsible for this phenotype was named amyR . Isolation of the amyR gene In order to rescue the amyR gene from the amylase * , lipase" transformants of ToC879, two different approaches were used successfully. DNA was prepared from mycelium grown in minimal medium with cyclodextrin as the carbon source. In the first approach the DNA was packaged into λ-heads using the Gigapack ® II kit from Stratagene in an attempt to rescue the original cosmid out of the total DNA. The packaging reaction was incubated with XLl-Blue MR E. coli under the conditions specified by the kit supplier. The E. coli cells were plated on LB plates with 50 μg/ml ampicillin. Two colonies appeared on the plates; the cosmids they contained were identical and named ToC1012. In the second approach the total DNA was used in an attempt to transform competent E. coli DH5a cells. Sixteen colonies were isolated and shown to contain six different plasmids by restriction enzyme digest . Each of the plasmids was digested with EcoRI and subjected to Southern analysis. A 32 P-labelled probe of a mixture of pMT1657 and SuperCosl was used to identify DNA fragments not part of any of these vectors. Two EcoRI fragments, approximately 0.7 and 1.2 kb in size, did not hybridize to any of these probes. The 1.2 kb fragment was isolated, labelled with 32 P and used as a probe in a hybridization experiment with the filters containing the part of the cosmid library that gave rise to the original transformants. Six cosmids from the pool (ToC904) , containing approximately 1000 clones did hybridize. Of these, some were shown by restriction enzyme digestion to be identical, resulting in the isolation of four different cosmids. All cosmids contained at least parts of the TAKA-amylase gene as well. The four cosmids and the cosmid ToC1012 were transformed into ToC879 by co-transformation with pMT1623, a pUC based plasmid that carries the bar gene under the control of the A . oryzae tpi promoter. Fifteen transformants from each co- transformation were isolated by resistance to glufosinate and tested for the ability to grow on cyclodextrin. Eight transformants of ToC1012 and three transformants of one of the other cosmids, 41B12, were able to grow. None of the transformants of the other cosmids grew. That not all of the transformants of ToC1012 and 41B12 were able to grow is likely to be a reflection of the co-transformation frequency in each experiment. Colonies from the transformants growing on cyclodextrin were analysed by RIE, and showed that they all produced lipase. DNA fragments obtained by digesting 41B12 with either Bglll, Hindlll or PstI were cloned into pUC19 in order to subclone amyR from the cosmid. The subclones were transformed into ToC879 and the transformants analysed for the ability to grow on cyclodextrin and produce lipase as described above. As depicted in Fig. 2, one plasmid called pToC316 was shown to contain an approximate 9 kb Hindlll fragment which was identified as containing amyR. Further subcloning resulted in a plasmid called pToC320 containing a 4.3 kb Hindlll/SacI fragment, which is shown in Fig. 3 and was subsequently sequenced on an ABI DNA sequencer using both further subcloning and primer walking. A DNA sequence of 3980 bp including the amyR gene is shown in SEQ ID NO: 1. The deduced amino acid sequence is shown in SEQ ID NO: 3 and reveals a Gal 4 -type zinc finger sequence between amino acids 28-54. Such sequences are known to bind to DNA (Reece, R.J., and Ptashne, M. (1993) Science 261 909-910). amyR maps close to one of the three amylase genes in IF04177, since it was isolated from a cosmid also containing amylase- specific DNA fragments. Mapping of the cosmid showed that the α- amylase gene and amyR are 5-6 kb apart. Southern analysis of genomic DNA showed that only one copy of amyR is present in IF04177, and confirmed that it maps close to one of the amylase genes . Analysis of amyR cDNA mRNA was made by the method of Wahleithner, J. A., et al . (1996, Curr. Genet . 29 395-403) from a culture of A . oryzae grown in maltose containing medium under conditions favorable for α- amylase production. Double stranded cDNA was made by standard procedures and used for PCR reactions with the following primers : oligodT primer: TTTTGTAAGCT 3 ± SEQ ID NO. 9 23087 CCCCAAGCTTCGCCGTCTGCGCTGCTGCCG SEQ ID NO . 6 20865 CGGAATTCATCAACCTCATCAACGTCTTC SEQ ID NO. 7 20866 CGGAATTCATCGGCGAGATAGTATCCTAT SEQ ID NO. 8 A PCR reaction with the primers 20866 and 23087 resulted in a fragment of approximately 1.1 kb. The fragment was digested with EcoRI and Hindlll; these restriction sites were incorporated into the primers, and cloned into a pUC19 vector cut with the same enzymes . The insert in the resulting plasmid was sequenced, the result located one intron in this part of the gene. The intron is indicated in SEQ ID NO: 2. Another PCR reaction with the oligodT primer and primer 20866 did not result in a distinct fragment. An aliquot of this reaction was used as the starting point for a new reaction with the oligodT primer and the primer 20865, which resulted in a fragment of approximately 1.1 kb. This fragment was digested with EcoRI and Hindlll and cloned into pUC19. Sequencing showed that the fragment contained the 3 ' part of amyR and another intron was located. This is also indicated in SEQ ID NO: 2. Three independent plasmids were sequenced at the 3' end and two polyA addition sites were located, one at bp no. 3827 and one at bp no. 3927. EXAMPLE 2 Quantification of glucoamylase synthesis in an amyR " strain A . oryzae produces a glucoamylase, encoded by the glaA gene, which is regulated by the same substances as α-amylase (Y. Hata et al . (1992) Curr. Genet. 22 85-91). In order to see whether amyR is also involved in regulation of glaA the synthesis of glucoamylase was measured under inducing conditions in the amyR ' strain ToC879 and in the amyR wt strain SRe440, from which ToC879 was directly derived. Conidiospores from each strain were inoculated in 10 ml YPM (YP containing 2% maltose) and grown for four days at 30 ° C Super- natants were collected and analysed for glucoamylase content by incubation with p-nitrophenyl a-D-glucopyranoside, a substrate that turns yellow when cleaved by glucoamylase. In the procedure used, 0.5 ml of fermentation broth was mixed with 1 ml of 0.1 M Na-acetate pH = 4.3, containing 1 mg/ml of the substrate. The samples were incubated for 3 hours at room temperature and 1.5 ml of 0.1 M Na 2 B 4 0 7 was added. The yellow colour was measured in a spectrophotometer at 400 nm. Control samples were made by mixing the supernatants first with the borate and then with the substrate solution. The results were: reaction-control (OD units) SRe440 0.655 ToC879 0.000 The absence of any OD reading in the sample taken from ToC879 clearly indicate that synthesis of glucoamylase of A . oryzae requires the expression of the AmyR transcription factor. EXAMPLE 3 Overexpression of AmyR A plasmid, pToC342, containing the coding region and 3' noncoding sequences of amyR fused to the promoter for the A . oryzae tpi gene was constructed. The tpi gene codes for triosephosphate isomerase, a constitutively expressed enzyme involved in primary metabolism. The A . oryzae tpi gene was isolated by crosshybridization with an A . nidulans cDNA clone according to the procedure of McKnight, G.L., et al , (1986, Cell 46 143-147) . Sequencing led to identification of the structural gene. The promoter used was a fragment of approximately 700bp immediately upstream of the coding region. pToC342 was able to complement the mutation in ToC879. To pToC342 was further added the A . oryzae pyrG gene and the resulting plasmid, pToC359, was transformed into JaL250, a pyrG mutant of JaL228 described in patent application DK1024/96 filed 1996-09-19. Strains containing multiple copies of pToC359 were found to synthesise increased levels of glucoamylase. Construction of pToC342 and pToC359 A PCR reaction was made with pToC320 as the template and the following primers: 8753 GTTTCGAGTATGTGGATTCC 8997 CGGAATTCGGATCCGAGCATGTCTCATTCTC The resulting fragment was cut with EcoRI/Apal to produce a fragment of approximately 180bp which was then cloned into pToC320 that had been digested with EcoRI/ Apal . The resulting plasmid, pToC336, was sequenced to confirm that the PCR fragment was intact. The 2.6kb BamHI/SacI fragment of pToC336 containing the coding region and the 3 ' untranslated sequence of amyR and an EcoRI /BamHI fragment of approximately 700bp containing the tpi promoter was cloned into EcoRl/SacI digested pUC19. The BamHI site downstream of the tpi promoter was introduced in vi tro, whereas the EcoRI site is an endogenous site from the original tpi clone. The resulting plasmid, called pToC342, was cut with Hindlll, dephosphorylated and ligated to a 1.8 kb Hindlll fragment containing the A . oryzae pyrG gene, resulting in a plasmid which was called pToC359. The structure of both pToC342 and pToC359 are shown in Fig. 4, wherein Ptpi represents the tpi promoter and TamyR represents the 3' noncoding region of amyR. The cloning of the pyrG gene has been previously described in WO 95/35385. Expression in A. oryzae JaL250 JaL250 is a pyrG mutant of JaL228 selected by resistance to 5- fluoro-orotic acid. JaL228 has been described in patent application DK1024/96 filed 1996-09-19. JaL250 was transformed with pToC359 using standard procedures and by selecting for relief of uridine requirement. The transformants were reisolated twice through conidiospores and grown for four days in YP + 2% maltose at 30°C Secreted glucoamylase was measured by the ability to cleave p-nitrophenyl a-D-gluco-pyranoside . The transformants had 5-31 arbitrary glucoamylase units/ml in the fermentation broth, while JaL228 had 2-3 units/ml. The best transformant was named ToC1200. Southern analysis showed that multiple copies of pToC359 had integrated into the genome of ToC1200. Because of the a-amylase promoter, ToC1200 may be used advantageously as a host strain for expression plasmids. EXAMPLE 4 Carbon catabolite repression of the TAKA-promoter The TAKA-amylase promoter is subject to carbon catabolite repression. In Aspergilli carbon catabolite repression is at least partially mediated via the transcriptional represser CreA, a homologue to S. cerevisiae MIG1. The DNA binding sites in promoters under CreA control are known to be GC-rich and seemingly identical to the MIG1 sites in S . cerevisiae . The TAKA-amylase promoter contains several potential CreA binding sites. To determine whether this promoter is involved in carbon catabolite repression, three such sites were mutated, but provided only partial relief of carbon catabolite repression. In contrast, introduction of copies of constitutively expressed AmyR in strains containing the modified promoter coupled to a reporter gene completely relieved repression of the reporter. Construction of a CreA site deleted TAKA-amylase promoter Three sites were identified as being potential CreA binding sites in the TAKA-amylase promoter by sequence comparison to known CreA and MIGl sites. The resulting sites have the following sequences: Site I CC££G.GTATTG Site II CCCCGGAGTCA Site III ATATGGCQGT The bases underlined were changed to A's because such changes are known to destroy MIGl binding sites. The substitutions were made using standard site-specific mutagenesis procedures. An expression vector, pToC297, containing the modified promoter and the 3' nontranscribed sequence of the glucoamylase gene from A . niger was constructed. pToC297 is identical to pToC68 described in WO 91/17243 except for the changes in the promoter. Both plasmids have a unique BamHI site between the promoter and the terminator. Expression of a lipase regulated by a CreA " TAKA-amylase promoter A BamHI fragment of approximately 950bp containing the cDNA encoding a Humicola lanuginosa lipase was cloned into pToC297. (The cloning and expression of the H. lanuginosa lipase has been previously described in EP 305 216.) The resulting plasmid, pToC298, was transformed into A . oryzae IF04177 by co- transformation with the A . nidulans amdS gene, and its structure is shown in Fig. 5, wherein Ptaka-creA represents the CreA binding site deficient TAKA-amalyase promoter. The transformants were reisolated twice through conidiospores and one such transformant, ToC1075, which produces lipase, was chosen for further evaluation. ToC1075 and a p960 transformant of IF04177 (previously described in EP 305 216) containing the lipase fused to the wild type TAKA-promoter were grown at 30°C in 10 ml YP containing 2% or 10% glucose. Samples were taken daily for analysis of lipase in the fermentation broth. The lipase content was measured by rocket immune electrophoresis using a polyclonal antibody raised against purified lipase. Spent fermentation broth from A . oryzae IF04177 did not react with the antibody. The glucose content of the fermentation broth was likewise measured daily using Tes-tape from Lilly. On day one, glucose was detected in all cultures, but on day two glucose could be detected only in cultures originally containing 10%. The results of lipase production, shown in Fig. 6, indicate that the wild type promoter is repressed until glucose is no longer present. Thus, when the glucose becomes exhausted, lipase begins to accumulate. Fig. 6 also shows that the modified promoter is not as tightly regulated, as low levels of lipase are produced in the presence of glucose in the 10% glucose fermentation. Thus, there is partial glucose derepression seen in ToC1075. Relief of carbon catabolite repression of lipase in ToC1075 by pToC3 2 ToC1075 was transformed with pToC342 by co-transformation with the bar-containing plasmid, pMT1623. Strains containing multible copies of pToC342 and which retained the lipase expression cassette were identified by Southern blot analysis; one such strain was. ToC1075 and ToC1139 were grown at 30°C in 10 ml YP containing either 2% or 10% glucose, and samples were assayed daily for lipase and glucose. The lipase was measured by cleavage of para-nitrophenyl-butyrate. The glucose content was measured with Tes-tape from Lilly. The results, shown in Fig. 7, indicate that ToC1075, as before, provides partial relief of glucose repression while lipase production by ToC1139 is independent of the presence of glucose . EXAMPLE 5 Southern analysis of A . niger for the amyR gene The syntheses of a-amylase and glucoamylase in A . niger, as in A . oryzae, are regulated by the carbon source. It is therefore likely that A . niger also contains an amyR gene. This hypothesis was tested by looking for cross-hybridization between the A . oryzae amyR gene and A . niger chromosomal DNA. 5 DNA was prepared from A . niger by conventional methods. The DNA was cut with BamHI, Bglll, EcoRI, Hindlll, Sail, Xmal or Xbal , and the resulting DNA fragments were separated by electrophoresis on an agarose gel . The DNA was then blotted onto a nitrocellulase membrane and hybridized with a 32 P- 10 labelled probe containing part of the structural A . oryzae amyR gene. The probe was made by PCR on pToC320 and starts at bp . no. 1683 and ends at bp . no. 2615 as shown in SEQ ID NO: 1. The hybridization was conducted in lOx Denhardt's solution, 5x SSC, lOmM EDTA, 1% SDS, 0.15 mg/ml polyA, 0.05 mg/ml yeast tRNA) at 15 50°C overnight. After hybridization the membrane was washed under conditions of increasing stringency and the radioactivity on the membrane analysed by a Phospholmager . Figure 8 shows the result when the membrane had been washed in 2x SSC, 0.1%SDS at 58 °C. Unique bands can be seen with several of the restriction 0 enzymes. Thus, the A . niger amyR gene can be cloned on the basis of this cross-hybridization result. REFERENCES CITED IN THE SPECIFICATION 5 Description : Dhawale and Lane (1993) NAR 21 5537-5546 Lachmund et al . (1993) Current Microbiology 26 47-51 30 Tada et al . (1991) Mol . Gen . Genet . 229 301-306 Tada et al . (1991) Agric . Biol . Chem . 55 1939-1941 35 Tsuchiya et al . (1992) Biosci . Biotech. Biochem. 56 1849-1853, Nagata et al . (1993) Mol . Gen . Genet . 237 251-260 Ford et al . , (1991), Protein Expression and Purification 2, 95- 107 Cunningham and Wells, (1989) Science 244 1081-1085 Needleman, S.B. and Wunsch, CD., (1970) Journal of Molecular Biology 48 443-453 Sambrook, J. , et al . , (1989), Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Lab.; Cold Spring Harbor, NY. WO 93/11249 WO 94/14953 Kelly and Kwon-Chung (1992) J. Bacteriol . 174 222-232 McKnight et al . (1985) The EMBO J. 4 2093-2099 EP 238 023 Kulmburg, P., et al . (1992) Molecular and Cellular Biology 12 1932-1939 Lutfiyya, L.L., and Johnston, M. (1996) Molecular and Cellular Biology 16 4790-4797 Examples : Feinberg, A. P. and Vogelstein, B. (1983) Anal. Biochem. 132:6- 13 N. Axelsen et al . in: A Manual of Quantitative Immunoelectro- phoresis, Blackwell Scientific Publications, 1973, Chapter 23 A. Johnstone and R. Thorpe, Immunochemistry in Practice, Blackwell Scientific Publications, 1982, pp. 27-31 O. Ouchterlony in: Handbook of Experimental Immunology (D.M. Weir, ed.), Blackwell Scientific Publications, 1967, pp. 655-706 D. Gems, I. L. Johnstone, and A. J. Clutterbuck, (1991) Gene 98 61-67 EP 531 372 B. Staubinger et al . (1992) Fungal Genetics Newsletter 39 82-83 M. E. Katz et al . (1990) Mol . Gen . Genet . 220 373-376 Christensen, T., et. al . , (1988) Biotechnology 6 1419-1422 Cove D.J., BBA (1966) 113 51-56 Reece, R.J., and Ptashne, M. (1993) Science 261 909-910 Wahleithner, J. A., et al . (1996) Curr. Genet. 29 395-403 Hata, Y., et al . (1992) Curr. Genet . 22 85-91 McKnight, G.L., et al , (1986, Cell 46 143-147) DK1024/96 WO 91/17243 EP 305 216 SEQUENCE LISTING ( 1 ) GENERAL INFORMATION : (i) APPLICANT: (A) NAME: Novo Nordis A/S (B) STREET: Novo Alle (C) CITY: Bagsvaerd (E) COUNTRY: Denmark (F) POSTAL CODE (ZIP) : DK-2880 (G) TELEPHONE: +45 4442 2668 (H) TELEFAX: +45 4442 6080 (ii) TITLE OF INVENTION: A transcription factor (iii) NUMBER OF SEQUENCES: 9 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.30 (EPO) (2) INFORMATION FOR SEQ ID NO : 1; (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3980 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Aspergillus oryzae <XI ) SEQUENCE DESCRIPTION : SEQ ID NO : 1 : TCTAGACCGG CCATCTOSIG GIOCGCCAAG TTCSATICΑGG AC031G IGT ACTIGCTICR 60 TΠAAGAAAC GGCACCCCΓC TCCCGI TCC GAACCQGAAT TCTAGCΓAGA. TGΠAIAIGIC 120 TIGADGAACC AGGICTCCAC QGGCAAATCC CTCACAATTC ATOGCCCCTC COCJITCCCA.T 180 OGAΓΠCTGC TACCTOCOCT GCAAGGCAAA ACATCCOCGT CAAAOGICCG AGQGGCAΠG 240 CCT3CAA3CT CTOGAOCATG AGAQGQGAAG CAACJICACGC TAGTIGCAAG GGTAIAQGIC 300 CTA03CAGCA ATGAQGTQGC TTCACCCCTA CGGACT3GGG ACAGCATCAT CAAGCCTΠT 360 GGGAA03IGA OGAAAGAGTA αCEGITAAGC OGAOGAΪOGG AGATCAATCT CIGCCGAGCA 420 AAGGACGAGA CCGGAAAAGA CT3IGTCTCAT TCTTOGGAGC AGITACAGm CITCOCTGIC 480 CQGAAATIOG AAACGITCCT GACCAATGCT GGCGAT. CAT. C TCATATCCCT AOGCIGATTG 540 CTCCATCCCC CGA3AAA1GC COGACA03AC GCTTGAGCCC TCAAAAGCTA. CTATTICTOS 600 AGAGATCCAT TCACCAGACT CAA3ACTOGC AAA.TACATCG TTCCCCACCT CATATTCCAA 660 GCT3CCTAAA CCCCTCCGCT GTOC03CT3A GGGTΠTCCA 030CATCTCT ACT3GIOCCA. 720 TGACQGGAGC ATC03ATQGC TTCCAG TT GQCT3GITGG GAΪGGACAAC AAGCTCCAAA 780 TAAGGGGAAT TΓGCCΓΠΌG TCCAGGAATC AACTCCCCCT GGGGACCAGC GGCTCAGCCC 84o AGGCTAAGAG 103AATATCG TCATAGACCT TOGGCTCATC GGAGG TCGG AGGTCTTAGG 900 ATCCTCΓΓCA ATΌCCATICA. TΓCICICTΓΓ TCACCTCQGC TΓCOOGAGAG TGGIGCCΓCC 960 CTΓACATCCC CACATCCIΌG ATGCAAGCCT CTGCTAOGCΓ GΓΓΓCΠTCA GAAGΠAGCAG 1020 GCΓAQGΠTCA CGATGAGCIG CCΓΓΓCAAAC CTGGAATAAC CAT AOGΠGA GACIΌTΓCΓA 1080 CΓΓCITGAAT TΌATCCCIGA CΓAGAGΓCIG CIUΓAATAIG CICTGΓGGCA OGGCCGCTCC 1140 CCTCGGQGTΓ GCTAAGGCIG ATΓΓATGCAC TCCGIACAGT ATΆACCCAGG GTΌGCIATAG 1200 ATTCCCTGCA TCΠCCAOGC TCCCTCACAA CCIGATTCCA CCATTCΠAA GCGGCCGΓΓA 1260 GCCIΌGATΌG QCTATAATΌG AGΓΓAACΓAT AAACACGACT CTACAACGAA CCOGATGIG 1320 AGΓΠGGAAC GAGTTGJΠAC CGATQGGTCC TCCCAΓΠCT TAGGACTGAC GOTAGGGGAC 1380 CITTAGGGCA CAGACΓAAAC CAAGACAAAG ATGGAGTAGA CTCCAGGTAG ATIAATTCCA 1440 ATcrrTcrrac CAAAGIAACG CΏGGGTTΠT TCCACCTGCA GCCΓL ΓΓΓΓ TΓΓCTΠTTT 1500 CΓΠTITTΓC TTTΠT ATT GΠCCCCAGA TITC ΓΓΓCΓ TΓΓΓCITCAA TCCIGAOJIT 1560 CTCAAC0CT3 ATGGCGACAC AGCCOGCITC GCIATCCCTC GCΠTTAOCT OGGCCATTCT 1620 TCΓACTIΌCΓ CΓCGCGGGAT GCCATCAΠT CEAAAGGCTC CACATCGGCG AGATAGEATC 1680 CTATCCGAGC ATGΓCΓCATΓ CΓCCAACCGA CAΓΓCCCΓCA ACATCGGAAA AGGAAATOGA 1740 GTCAACCCCA GAAAAGCCGC CIAAACAGGC CTGCGACAAT TCCCGIOGAC GCAAAATCAA 1800 GIGΓΓCΓAGA GacciTCCAT GCGACAAGIΌ CCAGOGΠCTΓ CΠ ΓCTCCT GΠCCIACAG i860 CGAOCTGCTC CCTOGCAAGG GCCCCAACTT CCGCACGCTC TACCCTCTOG CΓCCCATCCA 1920 TCCACTCGCC TCAOGACCAC GTCCTCTCAC CAAGGAATOG CIGCCCCCAA AOCCAGGQGC 1980 TTGCCATTIG GCGTCCCOGA αTicrcασcc CTCCACCGTIA GOSGAOQCCC AGΓATCIACA 2040 TCCAGACΓΓC TCGGAGΓCCT TCACIΌGACΓ ACCACCCCCA GATCIΌCTCΓ CCΓCIΌCCGA 2100 CTCGACAAAC TOGCTATIΌG ACΓCCTCCAC TATΌGGCGCA CTCCCCGCGC CA∞CCGICT 2160 GTOGAD3CCA AACCTTCTAG CCCATCTCAA LUL'LTLCCTC AAGTACCTCT TCCCGATCAT 2220 GccασrσσiG AGACAGGACC AGCIΌCAGCA GGACTGCCAC CAGCCOGAGC GCΠCTCIΌC 2280 CCAACGCΓAC GCΠTCATΓG CCQCΓCTATG CGCGGCCACG O^CATCCAAC TGAAGCIOGA 2340 03CT3CAGCA CCGGGTCCCG AGGOGGCTIC CG0303AGCC AGCCT03ACG GACATCCTAT 2400 CTTCTOQQGA GAAGAACIΌC TGGCTGAAGC CGIGOGOGCA AGAAAGGAAT ACAAOGΓGGΓ 246o CGACGAAATT AACATOGAAA ACCTCCTAAC CICCl'lt'l'lT CTCITCGCCG CCIACGGAAA 2520 CCΓAGACAGA CAGGATCAGG ccτασιτc CCΓATCICAG ACCAOCTCCA TOCTCITCAC 25βo ACIAGGCCIΆ CAAOGGGAAT CCACATACΓC GAAACΓAAGC CTCGAGGAAG CAGAAGAGAA 2640 AAQGAGAGΠΆ TTCTCGCICΓ TATIΌCTCAC AGAAAGCTAA GAAAAGAAAA AACΓCΓACΓΓ 2700 TCCCAATCAC CACCA XJTAC CAAAAA AAC ACX3AAAAACC AGAGGCIA03 CATTACAACA 2760 AGCAAAACCA GTCATGCΓCC GCAACICCAT OCACAAACCA CAGCTCCTOΓ GC CAGACGA 2820 CCCAATCCTA GCCTACGCCT TCATCAACCΓ CATCAACCTC TΓCGAAAAGC TCTCΓACGAC TGGGTCΓOCG CCGGOGGCAG CAGOGCAGAC GGCGACCCCC TTCΓATCCAA TCCAGΓCTCG CCAAGCAAAT CTCCCΓCGAG GGOCTCΓCCG ACTAGACATC CΓCATCACΓC AGCAATOGCΓ ACAAACCATC ATCIΌGAAAC CCACGICACA CAGCCCGGCT CICGCGATCA CGCCGTTCTC CCCTTCCACC ACTOGGCAAG GCCCTCATGG GCGTCATOGC CGCGGCATCC CAAGGTGCTG TCCTATOGGA ATGGTAAGAA AQCX-ACCTM CCTCATCACA CCCTCCCTCA CXXA.TCATCT ATACCCGCAA TCDVACAAAA ACOGCAGGAA CAAAAACTCT CACCTCCCTA GCCGAOGTCΓ CCCGCTCCCT AAGCACAAAA GCCGCCCACC ATCGACCATC GACCCCCGAG AACICCTCIG GGGCATTCIC ACAACCCTAT osσrrcccAA T ΆTACCΓCΓ TCCCAGCGCT OGIΌGAGCAA ACTOGAQGCA CGACIGTΓCG C ΓΓCCATCA GTCACΠTCΓ GCCΓΓCSΓΓT GGΠΌGGCCGC CJIΌGCGGAOG QGTCAATCIG GGTΠGATTT ATT3GGGATC GOGGATCATT GGAGAATGAG GGTGGGGAGG GGATKJIOGT GGCIGGGGAG GAGATTT03r CΓCΠTΓCΓΓ TΠΌCΓΠGΓ ασiσiuπσr GπGQσiGσr TCIGGGGGGG TATAOGCΠΌ ADGATOIGCA TTOQGAΠΌG GGΓ CCTACΓ QGΓATATAAT TIUEATATAG TCCGCIΌGAG ACGGIGCAAT GATGΓGGGGA TCAATCACΓΓ GGAGCACAGG GICTOGGΓΓC τo3Gστ τr CΓGAGEA GA GATEAIATAG TGATCATΓAT TCΓACATACC TTAAAGAAAG ATAIGCITOG CACCCCGATA AAACIΌGICΓ TCA IUIAGA ( 2 ) INFORMATION FOR SEQ ID NO : 2 : ( I ) SEQUENCE CHARACTERISTICS : (A) LENGTH: 3980 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Aspergillus oryzae (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION: 1691..2676 (ix) FEATURE: (A) NAME/KEY: intron (B) LOCATION: 2677..2742 (ix) FEATURE: (A) NAME/KEY: exon (B) LOCATION: 2743..3193 ( ix) FEATURE : (A) NAME/ KEY : intron (B) LOCATION : 3194 . . 3277 ( ix) FEATURE : (A) NAME/KEY: exon (B) LOCATION: 3278..3653 (ix) FEATURE: (A) NAME/KEY : CDS (B ) LOCATION : j oin ( 1691 . . 2676 , 2743 . . 3193 , 3278 . . 3653 ) (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 2 : TCEAGACCGG CCATGTOCTG CTCCGCCAAG TTGATTCCQG ACCG'lb lCT AGΠGCITCT 60 TΓΓAAGAAAC GGCACCCCTC TCCCCTCTCC GAACCGGAAT TCTAGCΓAGA TCEATATCΓC 120 TIUACGAACC AGG CTCCAC GGGCAAATCC CTCACAATIG ATOGCCCCTC CCGTTCCCAT 180 CGATΓ CTGC TACCIΌCCCT GCAAGGCAAA ACATCCCCGΓ CAAACCTCCG AQGQGCATIG 240 CCH3CAATCT CTCGACCATC AGAQGGGAAG CAACTCAOGC TAGITCCAAG GCTATAQCTC 300 CTACGCAGCA ATCAGGIGGC TTCACCCGEA COGACTAQQG ACAGCATCAT CAAGCCITTT 360 GQGAACCT3A OGAAAGAGTEA COGCTIAAGC CGACGATGQG AGA.TCAATCT CIGCOGAGCA 420 AAQGACGAGA CCGGAAAAGA GIGTGTIGAT TCITOQGAGC AGTMCACTA CITCCGKTIC 480 03GAAATTGG AAACGITCCT GACCAAT3CT GGOGATCATC TGATATCCCT ACGCIGATIG 540 GICCATCCCC CGATAAATGC CCGACAOSAC GCTIGAGCCC TGAAAAGCTA GIMTTCTCG 600 AGAGATCCAT TCAOCAGACT CAATACTGGC AAATACATQG TTCCCCACCT CATATTCCAA 660 σσiGC iAA CCCCΓCCGGT GIΌCOGCTGA GGGTΠTCCA c _A Cicr AGIΌGIGCCA 720 TGACGGGAGC ATCCGATGGC TTCCAGTATT GGCTGGTIGG GATOGACAAC AAGCTCCAAA 780 TAAQ3GGAAT TI - ITIUG TCCAGGAATC AAGTCCCOST GGGGACCAGC GGCTCAGCCC 840 AGGCTAAGAG TGGAATATOG TCATAGACCT TO3GCTCATG GGAGGTIOGG AGGTCITAOG 900 ATCCTCITCA AT3CCATTCA TTCTCIGΠTT TCACCTCGGC TTCCOGAGAG TGCT3CCTCC 960 CΠACATCCC CACAIGCIGG ATCCAAGCCT GIΌGEACECΓ GΠTCΠTCA GAAGTAGCAG 1020 GCΓAGGITCA CGATGAGCIG CCΠTCAAAC CIGGAAIAAC cκrmcαiGA GACΠJΠ IA IOΘO CΓΓCΠGAAT TCATCCCIGA CΓAGAGICIG CΓCΓAAIATC CTGIGIGGCA OGGCCGGICC 1140 CCIΌGGGGTT GCTAAGGCIG ATΠAIGCAC TCCGIACAGT ATAACCCAQG GIGGCΓAIAG 1200 ATTCCCTCCA TCΓΓCCACGC TCCCΓCACAA CCIGAΠΌCA CCATΓCΠAA GCGGCCGΓEA 1260 GCCTCGAT3G GCTATAATGG ACTTAACTAT AAACADGACT CEACAADGAA TCCCGA3X3IG 1320 AGΠTGGAAC GAGΠGΓEAC OGATGGGTCC TCCCAITHJΓ TAGGACTGAC GCTAGGGGAC i3βo CΠTAGGGCA CAGACΓAAAC CAAGACAAAG ATOGAGIAGA CTCCAGGΓAG ATTAATΓCCA 1440 ATΠTCΠGC CAAAGTCAACG CGGGGTΠTT TCCACCIGCA GCCΓCΓΓΠT TTTCΠTΠT 1500 CΓΠTTΠTC TΠTΠTA Γ JITCCCCAGA TΠ ΓΠTCΓ TTTTCΓΓCAA TCCIGACGΓΓ i560 crcAACcσiG ATGGCGACAC AGCCCGCTTC GCIATCCCTC GCΓΠTAOCJΓ CGGCCATΓCΓ 1620 TCTAGΠGCΓ C CGCGGGAT GCCATGATTT CEAAAQGCTC CACATOGGCG AGATACTATC 1680 CΓATCOGAGC ATG TCΓ CAT TCT CCA ACC GAC ATΓ CCC TCA ACA TCC GAA 1729 Met Ser His Ser Pro Thr Asp He Pro Ser Thr Ser Glu 1 5 10 AAG GAA ATG GAG TCA AOC CCA GAA AAG CCG CCT AAA CAG GCC TGC GAC 1777 Lys Glu Met Glu Ser Thr Pro Glu Lys Pro Pro Lys Gin Ala Cys Asp 15 20 25 AAT TGC CCT CGA CGC AAA ATC AAG TCT TCT AGA GAG CTT CCA TGC GAC 1825 Asn Cys Arg Arg Arg Lys He Lys Cys Ser Arg Glu Leu Pro Cys Asp 30 35 40 45 AAG TGC CAG CCT 1 CTT CTT CIC TCC TCT TCC TAC AOC GAC GIG CTC CCT 1873 Lys Cys Gin Arg Leu Leu Leu Ser Cys Ser Tyr Ser Asp Val Leu Arg 50 55 60 CGC AAG GGC ∞C AAG TTC CGC ACG CTC TAC CCT CTC GCT CCC ATC CAT 1921 Arg Lys Gly Pro Lys Phe Arg Thr Leu Tyr Pro Leu Ala Pro He His 65 70 75 CCA CTC GCC TCA CGA CCA CCT CCT CTC ACC AAG GAA TGG CIG CCC CCA 1969 Pro Leu Ala Ser Arg Pro Arg Pro Leu Thr Lys Glu Trp Leu Pro Pro 80 85 90 AAC CCA GGG GCT TGC CAT TTG GCG TCC CCG ACG TCT CCG CCG TCC ACC 2017 Asn Pro Gly Ala Cys His Leu Ala Ser Pro Thr Ser Pro Pro Ser Thr 95 100 105 GTTA GOG GAC GCC CAG TAT CEA CAT CCA GAC TTC TOG GAG TCG TTC ACT 2065 Val Ala Asp Ala Gin Tyr Leu His Pro Asp Phe Ser Glu Ser Phe Thr 110 115 120 125 CGA CTA CCA CCC CCA GAT CTC GIC TCC TCT CCC GAC TOG ACA AAC TCG 2113 Arg Leu Pro Pro Pro Asp Leu Val Ser Ser Pro Asp Ser Thr Asn Ser 130 135 140 CEA TTC GAC TOG TCC ACT ATC GGC GCA CTC CCC GCG CCA CGC CCT CIG 2161 Leu Hie Asp Ser Ser Thr He Gly Ala Leu Pro Ala Pro Arg Arg Leu 145 150 155 TCG ACG CCA AAC CTT CEA GCC CAT CTC AAT GIC TTC CTC AAG TAC CTG 2209 Ser Thr Pro Asn Leu Leu Ala His Val Asn Val Phe Leu Lys Tyr Leu 160 165 170 TTC CCG ATC ATG CCC CTC CTG AGA CAG GAC CAG CIG CAG CAG GAC TGC 2257 Phe Pro He Met Pro Val Val Arg Gin Asp Gin Leu Gin Gin Asp Cys 175 180 185 CAC CAG CCG GAG CGC TIG TCT CCC CAA CGC TAC GCT TTC ATT GCC GCT 2305 His Gin Pro Glu Arg Leu Ser Pro Gin Arg Tyr Ala Phe He Ala Ala 190 195 200 205 CTA TGC GOG GCC ACG CAC ATC CAA CIG AAG CIG GAC GCT GCA GCA CCG 2353 Leu Cys Ala Ala Thr His He Gin Leu Lys Leu Asp Gly Ala Ala Pro 210 215 220 GCT CCC GAG GCG GCT TCC GCG CGA GCC AGC CTC GAC GGA CAT CCT ATG 2401 Gly Pro Glu Ala Ala Ser Ala Arg Ala Ser Leu Asp Gly His Pro Met 225 230 235 TTG TOG GGA GAA GAA CTC CIG GCT GAA GCC CTG CGC GCA AGA AAG GAA 2449 Leu Ser Gly Glu Glu Leu Leu Ala Glu Ala Val Arg Ala Arg Lys Glu 240 245 250 TAC AAC CTG CTG GAC GAA ATT AAC ATG GAA AAC CTC CEA ACC TCC TTC 2497 Tyr Asn Val Val Asp Glu He Asn Met Glu Asn Leu Leu Thr Ser Phe 255 260 265 TTT CTC TTC GCC GCC TAC GGA AAC CTA GAC AGA CAG GAT CAG GCC TOG 2545 Phe Leu Phe Ala Ala Tyr Gly Asn Leu Asp Arg Gin Asp Gin Ala Trp 270 275 280 285 TTC TAC CTA TCT CAG ACC ACG TCC ATG GTC TTC ACA CTA GGC CTA CAA 2593 Phe Tyr Leu Cys Gin Thr Thr Ser Met Val Phe Thr Leu Gly Leu Gin 290 295 300 CGG GAA TCC ACA TAC TCG AAA CTA AGC CTC GAG GAA GCA GAA GAG AAA 2641 Arg Glu Ser Thr Tyr Ser Lys Leu Ser Val Glu Glu Ala Glu Glu Lys 305 310 315 AGG AGA CTA TTC TGG-CTC TEA TTC CTC ACA GAA AG GTAAGAAAAG 2686 Arg Arg Val Phe Trp Leu Leu Phe Val Thr Glu Arg 320 325 AAAAAACTCT ACTTTCCCAA TCACCACCAC GIACXΛAAAA TAACACGAAA AACCAG A 2743 GGC TAC GCA TTA CAA CAA GCA AAA CCA CTC ATG CIC CGC AAC TCC ATC 2791 Gly Tyr Ala Leu Gin Gin Ala Lys Pro Val Met Leu Arg Asn Ser He 330 335 340 345 CAC AAA CCA CAG GTC CIG TGC TCA GAC GAC CCA ATC CTA GCC TAC GGG 2839 His Lys Pro Gin Val Leu Cys Ser Asp Asp Pro He Leu Ala Tyr Gly 350 355 360 TTC ATC AAC CTC ATC AAC CTC TTC GAA AAG CTC AGC CCA AAT CTC TAC 2887 Phe He Asn Leu He Asn Val Phe Glu Lys Leu Ser Pro Asn Leu Tyr 365 370 375 GAC TOG GTC TCC GCC GGC GGC AGC AGC GCA GAC GGC GAC CCC COG CCT 2935 Asp Trp Val Ser Ala Gly Gly Ser Ser Ala Asp Gly Asp Pro Pro Pro 380 385 390 ACT TCT TCT ATC CAA TCC ACT CTC GCC AAG CAA ATC TCC CTC GAG GGC 2983 Thr Ser Ser He Gin Ser Ser Leu Ala Lys Gin He Ser Leu Glu Gly 395 400 405 CTC TCC GAG ATC CAG AAA CTA GAC ATC CTC ATC ACT CAG CAA TOG CIA 3031 Val Ser Glu He Gin Lys Val Asp He Leu He Thr Gin Gin Trp Leu 410 415 420 425 CAA ACC ATG ATG TOG AAA CTC TCC ATG ACC CAC CTC ACA CAG CCC GGC 3079 Gin Thr Met Met Trp Lys Leu Ser Met Thr His Val Thr Gin Pro Gly 430 435 440 TCT CGC GAT GAC GCC CTT CTC CCC TTC CAC CIG CCC CTG CTA CTC GGC 3127 Ser Arg Asp Asp Ala Val Leu Pro Phe His Leu Pro Val Leu Val Gly 445 450 455 AAG GCC CTC ATG GGC GTC ATC GCC GCG GCA TCC CAA GCT GCT CTT GAC 3175 Lys Ala Val Met Gly Val He Ala Ala Ala Ser Gin Gly Ala Val Asp 460 465 470 GCT CAT GCT ATC GGA ATG GTAAGAAAGC GACCTTACCT CATCACACCC 3223 Ala His Gly He Gly Met 475 TCCCTCATCA GTCACICCCC ATCATCIATA CCCGCAATCT AACAAAAACC GCAG GAA 3280 Glu 480 CAA AAA CTC TAC GAC CTC GGC ACC TCC GEA GCC GAC GTC TCC CGC TCC 3328 Gin Lys Leu Tyr Asp Leu Gly Thr Ser Val Ala Asp Val Ser Arg Ser 485 490 495 CEA AGC ACA AAA GCC GCC CAC CAC CTC GCC GAA TCG ACC ATC GAC CCC 3376 Leu Ser Thr Lys Ala Ala His His Leu Ala Glu Ser Thr He Asp Pro 500 505 510 OGA GAA CTC CTC TOG GGC ATT CTC ACA ACC CEA TCC CGA ATC CGC GCT 3424 Arg Glu Leu Leu Trp Gly He Leu Thr Thr Leu Ser Arg He Arg Gly 515 520 525 TCC CAA TCA TAC CTC TTC CCA GCG CTC GTC GAG CAA ACT CGA GGC ATC 3472 Ser Gin Ser Tyr Leu Phe Pro Ala Leu Val Glu Gin Ser Arg Gly He 530 535 540 ATC ACT TTC GAC TCT TCG CTT TCC ATC ACT GAC ITT CIG CCT TCG TTT 3520 He Ser Phe Asp Cys Ser Leu Ser He Ser Asp Phe Leu Pro Ser Phe 545 550 555 560 GCT GOG CCG CCG GCT ATT ATG TOG OGG ACG GCT GAA TCT GOG TTT GAT 3568 Gly Gly Pro Pro Ala He Met Trp Arg Thr Gly Glu Ser Gly Phe Asp 565 570 575 TEA TG GGG ATC GCG GAT GAT TTG CAA GAG AGG GAG AAT GAG GCT GGG 3616 Leu Leu Gly He Ala Asp Asp Leu Gin Glu Arg Glu Asn Glu Gly Gly 580 585 590 GAG GGG ATT GIG GIG GCT GGG GAG GAG ATT TCG TTT TGAGGGQGCT 3662 Glu Gly He Val Val Ala Gly Glu Glu He Ser Phe 595 600 CTΓΠCTTIT TCCΠTGTGG TCTGΠGICT TGGCTGCTTC TGGGQGGGCG GGQGTCTATA 3722 TACGCΠGAC GATCTGCATT GGGATTGGGG TTCCΓACIGG TATATAAΓAT GGATTCTΠT 3782 CTATATACTC CΣCIGGAGAC GCTGCAATGA TGIGGGGATC AATCACITCT TAGGACT03G 3842 AGCACAGGCT GTCGGTTCIC G3CTTATTCT GACTATGAGA TTATATAGAA TCACTEAATG 3902 ATCATTATTG TACAIACCTT AAAGAAAGAT ATGCTIGGCA OCCCGATATG ACAATAGAAA 3962 ACIGGTCTTC ATTCTAGA 3980 (2) INFORMATION FOR SEQ ID NO : 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 604 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: Met Ser His Ser Pro Thr Asp lie Pro Ser Thr Ser Glu Lys Glu Met 1 5 10 15 Glu Ser Thr Pro Glu Lys Pro Pro Lys Gin Ala Cys Asp Asn Cys Arg 20 25 30 Arg Arg Lys lie Lys Cys Ser Arg Glu Leu Pro Cys Asp Lys Cys Gin 35 40 45 Arg Leu Leu Leu Ser Cys Ser Tyr Ser Asp Val Leu Arg Arg Lys Gly 50 55 60 Pro Lys Phe Arg Thr Leu Tyr Pro Leu Ala Pro lie His Pro Leu Ala 65 70 75 80 Ser Arg Pro Arg Pro Leu Thr Lys Glu Trp Leu Pro Pro Asn Pro Gly 85 90 95 Ala Cys His Leu Ala Ser Pro Thr Ser Pro Pro Ser Thr Val Ala Asp 100 105 110 Ala Gin Tyr Leu His Pro Asp Phe Ser Glu Ser Phe Thr Arg Leu Pro 115 120 125 Pro Pro Asp Leu Val Ser Ser Pro Asp Ser Thr Asn Ser Leu Phe Asp 130 135 140 Ser Ser Thr lie Gly Ala Leu Pro Ala Pro Arg Arg Leu Ser Thr Pro 145 150 155 160 Asn Leu Leu Ala His Val Asn Val Phe Leu Lys Tyr Leu Phe Pro lie 165 170 175 Met Pro Val Val Arg Gin Asp Gin Leu Gin Gin Asp Cys His Gin Pro 180 185 190 Glu Arg Leu Ser Pro Gin Arg Tyr Ala Phe lie Ala Ala Leu Cys Ala 195 200 205 Ala Thr His lie Gin Leu Lys Leu Asp Gly Ala Ala Pro Gly Pro Glu 210 215 220 Ala Ala Ser Ala Arg Ala Ser Leu Asp Gly His Pro Met Leu Ser Gly 225 230 235 240 Glu Glu Leu Leu Ala Glu Ala Val Arg Ala Arg Lys Glu Tyr Asn Val 245 250 255 Val Asp Glu lie Asn Met Glu Asn Leu Leu Thr Ser Phe Phe Leu Phe 260 265 270 Ala Ala Tyr Gly Asn Leu Asp Arg Gin Asp Gin Ala Trp Phe Tyr Leu 275 280 285 Cys Gin Thr Thr Ser Met Val Phe Thr Leu Gly Leu Gin Arg Glu Ser 290 295 300 Thr Tyr Ser Lys Leu Ser Val Glu Glu Ala Glu Glu Lys Arg Arg Val 305 310 315 320 Phe Trp Leu Leu Phe Val Thr Glu Arg Gly Tyr Ala Leu Gin Gin Ala 325 330 335 Lys Pro Val Met Leu Arg Asn Ser lie His Lys Pro Gin Val Leu Cys 340 345 350 Ser Asp Asp Pro lie Leu Ala Tyr Gly Phe lie Asn Leu lie Asn Val 355 360 365 Phe Glu Lys Leu Ser Pro Asn Leu Tyr Asp Trp Val Ser Ala Gly Gly 370 375 380 Ser Ser Ala Asp Gly Asp Pro Pro Pro Thr Ser Ser lie Gin Ser Ser 385 390 395 400 Leu Ala Lys Gin lie Ser Leu Glu Gly Val Ser Glu lie Gin Lys Val 405 410 415 Asp lie Leu lie Thr Gin Gin Trp Leu Gin Thr Met Met Trp Lys Leu 420 425 430 Ser Met Thr His Val Thr Gin Pro Gly Ser Arg Asp Asp Ala Val Leu 435 440 445 Pro Phe His Leu Pro Val Leu Val Gly Lys Ala Val Met Gly Val lie 450 455 460 Ala Ala Ala Ser Gin Gly Ala Val Asp Ala His Gly lie Gly Met Glu 465 470 475 480 Gin Lys Leu Tyr Asp Leu Gly Thr Ser Val Ala Asp Val Ser Arg Ser 485 490 495 Leu Ser Thr Lys Ala Ala His His Leu Ala Glu Ser Thr lie Asp Pro 500 505 510 Arg Glu Leu Leu Trp Gly lie Leu Thr Thr Leu Ser Arg lie Arg Gly 515 520 525 Ser Gin Ser Tyr Leu Phe Pro Ala Leu Val Glu Gin Ser Arg Gly lie 530 535 540 lie Ser Phe Asp Cys Ser Leu Ser lie Ser Asp Phe Leu Pro Ser Phe 545 550 555 560 Gly Gly Pro Pro Ala lie Met Trp Arg Thr Gly Glu Ser Gly Phe Asp 565 570 575 Leu Leu Gly He Ala Asp Asp Leu Gin Glu Arg Glu Asn Glu Gly Gly 580 585 590 Glu Gly He Val Val Ala Gly Glu Glu He Ser Phe 595 600 (2) INFORMATION FOR SEQ ID NO : 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: primer 4650 (iii) HYPOTHETICAL: YES (iii) ANTI -SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 4: CTTGCATGCC GCCAGGACCG AGCAAG 26 (2) INFORMATION FOR SEQ ID NO : 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: primer 4651 (iii) HYPOTHETICAL: YES (iii) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5: CTTGGATCCT CTGTGTTAGC TTATAG 26 (2) INFORMATION FOR SEQ ID NO : 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: primer (iii) HYPOTHETICAL: YES (iii) ANTI-SENSE: NO (Xi) SEQUENCE DESCRIPTION: SEQ ID NO : 6: CCCCAAGCTT CGCCGTCTGC GCTGCTGCCG30 (2) INFORMATION FOR SEQ ID NO : 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29x base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: primer (iii) HYPOTHETICAL: YES (iii) ANTI -SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 7: CGGAATTCAT CAACCTCATC AACGTCTTC 29 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: primer (iii) HYPOTHETICAL: YES (iii) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: CGGAATTCAT CGGCGAGATA GTATCCTAT 29 (2) INFORMATION FOR SEQ ID NO : 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 41 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: primer (iii) HYPOTHETICAL: YES (iii) ANTI -SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 9: H H H •-3 H H H H ι-3 ι-3 H ι-3

Claims: expression of an α-amylase promoter in a filamentous fungus, encoded by a DNA sequence comprising the DNA sequence defined in a) , or iv) encodes a transcription factor which is immunologically reactive with an antibody raised against the purified transcription factor encoded by the DNA sequence defined in a) , or v) complements the mutation in ToC879, i.e. makes ToC879 able to grow on cyclodextrin and produce lipase when transformed with said DNA sequence. 8. The DNA construct according to any of the claims 5 to 7, in which said DNA sequence is obtainable from a filamentous fungus . 9. The DNA construct according to claim 8, in which said filamentous fungus belongs to any of the groups Phycomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and fungi imperfecti, including Hyphomycetes such as the genera Aspergillus, Penicillium, Trichoderma, Fusarium and Humicola , in particular a strain from Aspergillus sp., and especially from A . oryzae . 10. The DNA construct according to claim 9, in which said DNA sequence is isolated from or produced on the basis of a DNA library of an Aspergillus oryzae strain. 11. The DNA construct according to claim 5 to 8 , in which said DNA sequence is obtainable from a yeast strain, especially of , Saccharomyces . 12. The DNA construct according to claim 7, in which the DNA sequence is isolated from Eschericia coli DSM 10666. 13. A recombinant expression vector comprising a DNA construct according to any of claims 5 to 12. 14. A cell comprising a DNA construct according to any of claims 5 to 12, or a recombinant expression vector according to claim 13. 15. The cell according to claim 14, which is a eukaryotic cell, in particular a fungal cell, such as a yeast cell or a filamentous fungal cell. 16. The cell according to claim 15, which is a strain of Aspergillus sp, in particular a strain of A . niger or A . oryzae . 17. The cell according to claim 15, which is a strain of Trichoderma sp., in particular T. reesei . 18. The cell according to claim 15, which is a strain of Saccharomyces , in particular a strain of S. cerevisiae . 19. A method of producing a polypeptide of interest comprising growing a cell of any of the claims 14 to 18 under conditions conducive to the production of said factor and said polypeptide of interest, and recovering said polypeptide of interest. 20. The method of claim 19, wherein said fungus is a fungus of the genus Aspergillus, Trichoderma, Penicillium, Fusarium or Humicola . 21. The method of claim 20, wherein said cell is of the species A . oryzae, A . niger, or A . awamori . 22. The method of claim 19, 20, or 21, wherein said polypeptide of interest is a medicinal polypeptide. 23. The method of claim 22, wherein said medicinal polypeptide is a growth hormone, insulin, or a blood clotting factor. 24. The method of claim 19, 20, or 21, wherein said polypeptide is an industrial enzyme. 25. The method of claim 24, wherein said industrial enzyme is a carbonyl hydrolase, carbohydrase, protease, lipase, amylase, cellulase, oxido reductase, glucoamylase, or esterase. 26. Use of a factor of any of the claims 1 to 4 for enhancing the expression of a polypeptide of interest in a filamentous fungus . 27. The use of claim 26, wherein said factor is the factor of claim 4. 28. The use of claim 27, wherein said fungus is a fungus of the genus Aspergillus, Penicillium, Trichoderma, Fusarium and Humicola, in particular a strain from Aspergillus sp . , and especially from A . oryzae sp. 29. The use of claim 28, wherein said fungus is of the species A . oryzae, A . niger, A . awamori , T. reesei , or T. harzianum. 30. The use of any of the claims 26 to 29, wherein said polypeptide of interest is a medicinal polypeptide. 31. The use of claim 30, wherein said medicinal polypeptide is a growth hormone, insulin, or blood clotting factor. 32. The use of any of the claims 26 to 29, wherein said polypeptide is an industrial enzyme. 33. The use of claim 32, wherein said industrial enzyme is a carbonyl hydrolase, carbohydrase, protease, lipase, amylase, cellulase, oxido reductase, glucoamylase, or esterase.

Inventors: CHRISTENSEN TOVE, CHRISTENSEN, TOVE
Applicants: CHRISTENSEN TOVE, NOVONORDISK AS, CHRISTENSEN, TOVE, NOVO NORDISK A/S
Application year: 1997
Main classification: C07K14
IPC codes: A61K38, C07K14, C12N1, C12N9, C12N15, C12R1